Management of Transfusion-Dependent Myelodysplastic Syndromes: Current and Emerging Strategies

ISSN： 1175-6357

Source： American Journal of Cancer, Vol.5, Iss.2, 2006-01, pp. : 71-80

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment Strategies in Myelodysplastic Syndromes

By Atallah Ehab Garcia-Manero Guillermo

Cancer Investigation, Vol. 26, Iss. 2, 2008-02 ,pp. : 208-216

Informa Healthcare

Access to resources Recommend Favorite

Chemotherapy-Associated Thrombocytopenia: Current and Emerging Management Strategies

By Jelic Svetislav

American Journal of Cancer, Vol. 5, Iss. 6, 2006-01 ,pp. : 371-382

Adis International

Access to resources Recommend Favorite

Current and Emerging Strategies in Bladder Cancer

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 6, 2012-07 ,pp. : 589-603

Bentham Science Publishers

Access to resources Recommend Favorite

Transfusiondependent lowrisk myelodysplastic patients receiving deferasirox: Longterm followup

Oncology Letters, Vol. 6, Iss. 6, 2013-01 ,pp. : 1774-1778

Spandidos Publications

Access to resources Recommend Favorite

Myelofibrosis in primary myelodysplastic syndromes: Clinical and Biological Significance

By Marisavljević D. Rolović Z. Ćemerikić V. Bošković D. Ćolović M.

Medical Oncology, Vol. 21, Iss. 4, 2004-12 ,pp. : 325-331

Humana Press, Inc

Access to resources Recommend Favorite